Bellevue Group »

Immunocore Holdings Plc- shares owned by Bellevue Group

Quarter-by-quarter ownership of Immunocore Holdings Plc- (IMCR) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Immunocore Holdings Plc-

Tip: Access up to 7 years of quarterly data

All positions including Immunocore Holdings Plc- held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunocore Holdings Plc- by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $67M 976k 68.32
2023-09-30 $1.0M 20k 51.90

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Intra Cellular Therapies (ITCI)
Moderna (MRNA)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Abbott Laboratories (ABT)
Revolution Medicines (RVMD)
Stryker Corporation (SYK)
Incyte Corporation (INCY)
Axonics Modulation Technolog (AXNX)
Dex (DXCM)

View all positions for Bellevue Group

Top funds holding Immunocore Holdings Plc-

Wellington Management Company
T. Rowe Price Associates
Baker Bros. Advisors
Paradigm Biocapital Advisors
Bellevue Group
Fiera Capital Corporation
Braidwell
Bill & Melinda Gates Foundation
Cowen And Company
Principal Financial Group
Tang Capital Management
Logos Global Management
TD Asset Management
First Turn Management
Massachusetts Financial Services

View all funds holding Immunocore Holdings Plc-